Revenue grew 46% year-over-year to $15.6 million, with gross margin expanding to 59% and net loss narrowing by more than half. The company completed its pivot to Bio-Native AI, divested non-core assets, launched recurring revenue platforms, and strengthened its balance sheet.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.